Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Julia C, Chisholm"'
Autor:
Julia C. Chisholm, Reineke A. Schoot, Alison L. Cameron, Michela Casanova, Veronique Minard-Colin, Beatrice Coppadoro, Marta Garrido, Timothy Rogers, Daniel Orbach, Heidi Glosli, Miriam Ben-Arush, Sima Ferman, Giovanni Scarzello, Rick R. van Rijn, Raquel Hladun, Nadege Corradini, Andrea Ferrari, Meriel Jenney, Gianni Bisogno, Johannes H.M. Merks
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100018- (2023)
Purpose: Patients with metastatic rhabdomyosarcoma (MTS RMS) and lung as the only metastatic site have better reported outcomes than other patients with MTS RMS. We analysed patients with lung-only MTS RMS receiving standard treatment within the EpSS
Externí odkaz:
https://doaj.org/article/bb8c7f0da2cc492fb4de7fd1fd83622f
Autor:
Julia C Chisholm, Oscar Lyons, Sarah Barclay, Liz Forbat, Rohana Ramachandran, Victoria Felton, Esse Menson, Charlotte Sayer, Kate Pryde, Siobhan Conlin, Susanne Ingle, Celia McKenzie, Carly Snowball, Emma Strachan-Gadsby, Natasha Tisovszky
Publikováno v:
BMJ Paediatrics Open, Vol 5, Iss 1 (2021)
Objective To implement and evaluate the use of the conflict management framework (CMF) in four tertiary UK paediatric services.Design Mixed methods multisite evaluation including prospective pre and post intervention collection of conflict data along
Externí odkaz:
https://doaj.org/article/c5ef2c3ac99d48948fb37b9434a9e1bc
Autor:
Elizabeth A. Corley, Erika Pace, Alex M. Barnacle, Premal A. Patel, Khin Thway, Julia C. Chisholm
Publikováno v:
Journal of Pediatric Hematology/Oncology. 45:e279-e284
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50ec83f4bd357d4c020dee9a00b67af3
https://doi.org/10.1097/mph.0000000000002612
https://doi.org/10.1097/mph.0000000000002612
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Desmoplastic small round cell tumor (DSRCT) is a devastating disease which most commonly affects adolescents, with a male predominance. Despite the best multimodality treatment efforts, most patients will ultimately not survive more than 3–5 years
Externí odkaz:
https://doaj.org/article/d7c161b1783b4500babb3a69353daee3
Autor:
Susanne A. Gatz, Ewa Aladowicz, Michela Casanova, Julia C. Chisholm, Pamela R. Kearns, Simone Fulda, Birgit Geoerger, Beat W. Schäfer, Janet M. Shipley
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Rhabdomyosarcomas are the most common pediatric soft tissue sarcoma and are a major cause of death from cancer in young patients requiring new treatment options to improve outcomes. High-risk patients include those with metastatic or relapsed disease
Externí odkaz:
https://doaj.org/article/4fc4f77910684cc7bfb2bc64c293d211
Autor:
Pablo Berlanga, Daniel Orbach, Reineke A. Schoot, Michela Casanova, Rita Alaggio, Nadege Corradini, Bernadette Brennan, Gema L. Ramirez‐Villar, Lisa Lyngsie Hjalgrim, Julia C. Chisholm, Gianni Bisogno, Beatrice Coppadoro, Akmal Safwat, Johannes H. M. Merks, Gabriela Guillen Burrieza, Max M. van Noesel, Andrea Ferrari
Publikováno v:
Pediatric Blood & Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90cf98726f3c236066b025a6b61e6095
https://doi.org/10.1002/pbc.30447
https://doi.org/10.1002/pbc.30447
Autor:
Andrea Ferrari, Daniel Orbach, Michela Casanova, Max M. van Noesel, Pablo Berlanga, Bernadette Brennan, Nadege Corradini, Reineke A. Schoot, Gema L. Ramirez‐Villar, Lisa Lyngsie Hjalgrim, Rita Alaggio, Gabriela Guillen Burrieza, Akmal Safwat, Alison L. Cameron, Rick R. van Rijn, Veronique Minard‐Colin, Ilaria Zanetti, Gianni Bisogno, Julia C. Chisholm, Johannes H. M. Merks
Publikováno v:
Cancer. John Wiley and Sons Inc.
Background: Limited data exist on the clinical behavior of pediatric non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) with distant metastases at onset, and a clear standard of care has not yet been defined. Methods: This cohort study reports on pedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b14d1265b3a064e8050b275a6fe01522
https://doi.org/10.1002/cncr.34814
https://doi.org/10.1002/cncr.34814
Autor:
Reda Stankunaite, Sally L. George, Lewis Gallagher, Sabri Jamal, Ridwan Shaikh, Lina Yuan, Debbie Hughes, Paula Z. Proszek, Paul Carter, Grzegorz Pietka, Timon Heide, Chela James, Haider Tari, Claire Lynn, Neha Jain, Laura Rey Portela, Tony Rogers, Sucheta J. Vaidya, Julia C. Chisholm, Fernando Carceller, Elwira Szychot, Henry Mandeville, Paola Angelini, Angela B. Jesudason, Michael Jackson, Lynley V. Marshall, Susanne A. Gatz, John Anderson, Andrea Sottoriva, Louis Chesler, Michael Hubank
Publikováno v:
European Journal of Cancer. 162:209-220
Clinical diagnostic sequencing of circulating tumour DNA (ctDNA) is well advanced for adult patients, but application to paediatric cancer patients lags behind.To address this, we have developed a clinically relevant (67 gene) NGS capture panel and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edcedb32be66e248bdc667dcd2ff184f
https://doi.org/10.1016/j.ejca.2021.09.042
https://doi.org/10.1016/j.ejca.2021.09.042
Autor:
Hiroaki Goto, Laura Dima, Steven G. DuBois, Ricarda Norenberg, Jordan R. Hansford, Esther De La Cuesta, Juneko E. Grilley-Olson, Ingrid Øra, David S. Hong, Theodore W. Laetsch, Karsten Nysom, Joanna Stefanowicz, Martin Højgaard, Valentina Boni, Hyoung Jin Kang, Julia C. Chisholm, Makoto Tahara, Birgit Geoerger, François Doz, Soledad Gallego-Melcon, David S. Ziegler, Alexander Drilon, Cornelis M. van Tilburg, Hyun Cheol Chung, Anne Thorwarth, Igor T. Gavrilovic, Antoine Italiano, Michael Capra, Sébastien Perreault, Nicolas U. Gerber
Publikováno v:
Neuro-Oncology. 24:997-1007
Background Larotrectinib is a first-in-class, highly selective tropomyosin receptor kinase (TRK) inhibitor approved to treat adult and pediatric patients with TRK fusion-positive cancer. The aim of this study was to evaluate the efficacy and safety o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1687c873049c47af75e3acbcc822a43d
https://doi.org/10.1093/neuonc/noab274
https://doi.org/10.1093/neuonc/noab274
Autor:
Reineke A. Schoot, Julia C. Chisholm, Michela Casanova, Veronique Minard-Colin, Birgit Geoerger, Alison L. Cameron, Beatrice Coppadoro, Ilaria Zanetti, Daniel Orbach, Anna Kelsey, Timothy Rogers, Cecile Guizani, Markus Elze, Myriam Ben-Arush, Kieran McHugh, Rick R. van Rijn, Sima Ferman, Soledad Gallego, Andrea Ferrari, Meriel Jenney, Gianni Bisogno, Johannes H.M. Merks
Publikováno v:
Scientia
Journal of clinical oncology, 19(32):JCO.21.02981, 3730-3740. American Society of Clinical Oncology
Journal of clinical oncology, 19(32):JCO.21.02981, 3730-3740. American Society of Clinical Oncology
PURPOSE Outcome for patients with metastatic rhabdomyosarcoma (RMS) is poor. This study presents the results of the MTS 2008 study with a pooled analysis including patients from the concurrent BERNIE study. PATIENTS AND METHODS In MTS 2008, patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba487c58a9b7c2c5a505d6da4056f724
https://hdl.handle.net/11351/8544
https://hdl.handle.net/11351/8544
